Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3251294 | 1.00 | GAA (0.47) | GAAKMT2AMEN1ALOX5ESR1 | |
| SCHEMBL20390735 | 0.99 | GAA (0.49) | GAAKMT2AMEN1ALOX5ESR1 | |
| SCHEMBL22991673 | 0.99 | GAA (0.49) | GAAKMT2AMEN1ALOX5ESR1 | |
| SCHEMBL17491358 | 0.95 | ESR1 (0.49) | GAAKMT2AMEN1ESR1 | |
| SCHEMBL284545 | 0.95 | ESR1 (0.49) | GAAKMT2AMEN1ESR1 | |
| SCHEMBL17491170 | 0.95 | ESR1 (0.49) | GAAKMT2AMEN1ESR1 | |
| SCHEMBL974962 | 0.95 | GAA (0.46) | GAAKMT2AMEN1ALOX5ESR1 | |
| SCHEMBL667600 | 0.95 | ESR1 (0.49) | GAAKMT2AMEN1ESR1 | |
| SCHEMBL284525 | 0.95 | ESR1 (0.49) | GAAKMT2AMEN1ESR1 | |
| SCHEMBL283674 | 0.95 | ESR1 (0.49) | GAAKMT2AMEN1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 908 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630732-B2 | Scattering particle, ink composition including the same, and display apparatus including quantum dot layer prepared by using the ink composition | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-05-19 | — | — | US | claimed |
| US-20250346751-A1 | ACRYLONITRILE STYRENE ACRYLATE COPOLYMER COMPOSITION WITH IMPROVED UV RESISTANCE | INEOS STYROLUTION GROUP GMBH (DE) | 2025-11-13 | — | — | US | claimed |
| US-20250277103-A1 | AN AQUEOUS ANTIOXIDANT SUSPOEMULSION AND A PROCESS FOR PREPARING THE SAME | BASF SE (DE) | 2025-09-04 | — | — | US | claimed |
| US-20240059921-A1 | SCATTERING PARTICLE, INK COMPOSITION INCLUDING THE SAME, AND DISPLAY APPARATUS INCLUDING QUANTUM DOT LAYER PREPARED BY USING THE INK COMPOSITION | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-02-22 | — | — | US | claimed |
| WO-2023202971-A1 | AN AQUEOUS ANTIOXIDANT SUSPOEMULSION AND A PROCESS FOR PREPARING THE SAME | BASF SE (DE) | 2023-10-26 | — | — | WO | claimed |
| EP-3426742-B1 | PHOTOCURABLE SILICONE COMPOSITION AND CURED PRODUCT THEREOF | DOW SILICONES CORP (US) | 2020-02-05 | — | — | EP | claimed |
| EP-3019474-B1 | LIGHT STABILIZERS | BASF SE (DE) | 2019-09-11 | — | — | EP | claimed |
| US-9969864-B2 | Light stabilizers | BASF SE (DE) | 2018-05-15 | — | — | US | claimed |
| EP-2408297-B1 | FORMULATION COMPRISING AVERMECTIN PARTICLES COATED WITH A PHOTO-PROTECTING AGENT | SYNGENTA LTD (GB) | 2016-11-30 | — | — | EP | claimed |
| US-20160168356-A1 | NOVEL LIGHT STABILIZERS | BASF SE (DE) | 2016-06-16 | — | — | US | claimed |
| EP-1951939-A2 | SPANDEX HAVING ENHANCED WHITENESS, AND FABRICS AND GARMENTS COMPRISING THE SAME | INVISTA Technologies S.à.r.l. (CH) | 2008-08-06 | — | — | EP | claimed |
| EP-1925628-A1 | Process for polyolefin silane crosslinking | Ciba Holding Inc. (CH) | 2008-05-28 | — | — | EP | claimed |
| US-20070174972-A1 | SPANDEX HAVING ENHANCED WHITENESS, AND FABRICS AND GARMENTS COMPRISING THE SAME | INVISTA NORTH AMERICA S.A R.I. (US) | 2007-08-02 | — | — | US | claimed |
| WO-2007059109-A2 | SPANDEX HAVING ENHANCED WHITENESS, AND FABRICS AND GARMENTS COMPRISING THE SAME | INVISTA TECHNOLOGIES S.A R.L. (CH) | 2007-05-24 | — | — | WO | claimed |
| JP-2007510767-A | — | — | 2007-04-26 | — | — | JP | claimed |
| US-20070027243-A1 | Stabilizer compositions for halogen containing polymers | CIBA SPECIALTY CHEMICALS CORP. | 2007-02-01 | — | — | US | claimed |
| EP-1680463-A2 | STABILIZER COMPOSITIONS FOR HALOGEN CONTAINING POLYMERS | Ciba SC Holding AG (CH) | 2006-07-19 | — | — | EP | claimed |
| WO-2005049715-A2 | STABILIZER COMPOSITIONS FOR HALOGEN CONTAINING POLYMERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-06-02 | — | — | WO | claimed |
| US-6573312-B2 | Physical and mechanical properties and biocompatibility | DENTKIST CO. LTD. (KR) | 2003-06-03 | — | — | US | claimed |
| EP-0069702-B1 | STOP CHAIN AGENT FOR VINYLCHLORIDE POLYMERISATION | CIBA-GEIGY AG (CH) | 1985-06-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168356-A1 | NOVEL LIGHT STABILIZERS | QDPR, CRY1, CRYZ | GAA 2171/4885KMT2A 3107/4885MEN1 4415/4885 |
| US-12630732-B2 | Scattering particle, ink composition including the same, and display apparatus including quantum dot layer prepared by using the ink composition | IK, INCENP, TYR | GAA 2479/4885KMT2A 2200/4885MEN1 4342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.